BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 288 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $375,000 | +61.6% | 2,578 | +31.6% | 0.00% | – |
Q1 2022 | $232,000 | -3.7% | 1,959 | +1.3% | 0.00% | – |
Q4 2021 | $241,000 | -87.2% | 1,934 | -91.2% | 0.00% | -100.0% |
Q4 2020 | $1,889,000 | +54.2% | 22,045 | -2.0% | 0.00% | +100.0% |
Q4 2019 | $1,225,000 | -26.6% | 22,500 | -43.8% | 0.00% | -50.0% |
Q3 2019 | $1,669,000 | -19.8% | 40,000 | -15.8% | 0.00% | 0.0% |
Q2 2019 | $2,080,000 | +58.5% | 47,500 | +86.3% | 0.00% | 0.0% |
Q1 2019 | $1,312,000 | +254.6% | 25,500 | +155.0% | 0.00% | +100.0% |
Q4 2018 | $370,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |